AAAAAA
Results:
1-7
|
Results: 7
Authors:
Miravitlles, M
Ros, F
Cobos, A
Kubin, R
Tillotson, G
Citation: M. Miravitlles et al., The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis:A spanish physician and patient experience, INT J CL PR, 55(7), 2001, pp. 437-441
Authors:
Iannini, PB
Kubin, R
Reiter, C
Tillotson, G
Citation: Pb. Iannini et al., Reassuring safety profile of moxifloxacin, CLIN INF D, 32(7), 2001, pp. 1112-1114
Authors:
Landen, H
Moller, M
Tillotson, GS
Kubin, R
Hoffken, G
Citation: H. Landen et al., Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin, J INT MED R, 29(2), 2001, pp. 51-60
Authors:
Lorenz, J
Thate-Waschke, IM
Mast, O
Kubin, R
Rychlik, R
Pfeil, T
Daniel, D
Tillotson, GS
Citation: J. Lorenz et al., Treatment outcomes in acute exacerbations of chronic bronchitis: Comparison of macrolides and moxifloxacin from the patient perspective, J INT MED R, 29(2), 2001, pp. 74-86
Authors:
Read, RC
Kuss, A
Berrisoul, F
Kearsley, N
Torres, A
Kubin, R
Citation: Rc. Read et al., The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis, RESP MED, 93(4), 1999, pp. 252-261
Authors:
Wilson, R
Kubin, R
Ballin, I
Deppermann, KM
Bassaris, HP
Leophonte, P
Schreurs, AJM
Torres, A
Sommerauer, B
Citation: R. Wilson et al., Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis, J ANTIMICRO, 44(4), 1999, pp. 501-513
Authors:
Redmond, A
Sweeney, L
MacFarland, M
Mitchell, M
Daggett, S
Kubin, R
Citation: A. Redmond et al., Oral ciprofloxacin in the treatment of Pseudomonas exacerbations of paediatric cystic fibrosis: Clinical efficacy and safety evaluation using magnetic resonance image scanning, J INT MED R, 26(6), 1998, pp. 304-312
Risultati:
1-7
|